Metformin Recall June 2025. A batch of metformin has been withdrawn by the medicine and healthcare products regulatory agency (mhra) as it is thought to contain “above accepted levels” of nitrosodimethylamine (ndma), which is known to. Several pharmaceutical manufacturers have recalled metformin in recent months due to the presence of ndma.
A class ii recall has been issued for more than 12,000 bottles of metformin hydrochloride meant to treat type 2 diabetes mellitus. Fda said in a press release in june that its testing found.